Rare chance
The difficulties of identifying and treating rare diseases
The difficulties of identifying and treating rare diseases
How pharma can utilise the power of Nordic real-world data
From data to action – the healthcare revolution is gaining momentum
The age-old challenge of diversity in clinical studies
Overcoming time perception challenges in dementia through technology
How can pharma re-engage with primary care?
Pierre Morgon is Executive Vice President of Portfolio Strategy and Supranational Affairs, as well as Managing Director Europe, at CanSino Biologics
The ‘Clinician of the Future 2023’ report suggests that healthcare professionals are preparing to embrace generative AI